Skip to content

Clinical trials

Phase 1 Parkinsonian Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Phase: Phase 1 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20131
20171
20181
20191
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Not yet recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cerevel Therapeutics, LLC1
Duke University1
Fundacion Clinic per a la Recerca Biomédica1
Johns Hopkins University1
Krzysztof Bankiewicz1
Mayo Clinic1
Neurocrine Biosciences1
PureIMS B.V.1
Qianfoshan Hospital1
Rabin Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders13
Parkinson Disease11
Central Nervous System Diseases3
Movement Disorders3
Neurodegenerative Diseases3
Brain Diseases2
Nervous System Diseases2
Basal Ganglia Diseases1
Dermatitis, Seborrheic1
Mobility Limitation1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.